EVIO Inc. Granted Expanded
Accreditation to Test for Pesticides and Residual
Solvents
BEND, OR -- November 22, 2017 -- InvestorsHub NewsWire --
EVIO, Inc. (OTCQB:
EVIO), a life science company and leading provider of quality
control testing and advisory services to the regulated cannabis
industry, announced that it has been granted an expansion to its
accreditations from the Oregon Environmental Laboratory
Accreditation Program (ORELAP), a division of the Oregon Health
Authority.
The expanded accreditations include the ability for EVIO Labs to
provide full-scope pesticide testing at its Medford location. The
Company also attained additional accreditation to test for residual
solvent residues at its Portland location. Together, the added
accreditations will enable EVIO to substantially reduce its testing
costs and improve customer satisfaction by decreasing turnaround
time by eliminating the reliance of third party testing
providers.
"EVIO Labs has made substantial investment during the past year
to achieve this milestone. During the last twelve months we have
been focused on adapting to a new regulatory environment,
increasing revenues, standardizing operations, and preparing for
growth. These new accreditations in Oregon will enable the company
to substantially reduce, if not nearly eliminate, our
subcontracting costs. The last fiscal year these expenses alone
topped $1 million," commented EVIO CEO, William Waldrop. "Bringing
pesticide testing fully in-house and expanding our capability with
residual solvent analysis will also allow us to substantially
increase our market opportunity and simultaneously become an even
more formidable competitor statewide."
About EVIO, Inc.
EVIO, Inc. is a life science company focused on advancing and
analyzing cannabis as a means for improving quality of life. The
Company provides analytical testing services, advisory services and
performs product research in its accredited laboratory testing
facilities. The Company's EVIO Labs division operating
coast-to-coast provides state-mandated ancillary services to ensure
the safety and quality of the nation's cannabis supply.
For more information, visit www.eviolabs.com
Safe Harbor Statement
Any statements in this press release that are not statements of
historical fact maybe considered to be forward-looking statements.
Statements may contain certain forward-looking statements
pertaining to future anticipated or projected plans, performance
and developments, as well as other statements relating to future
operations and results. Words such as "may," "will," "expect,"
"believe," "anticipate," "estimate," "intends," "goal,"
"objective," "seek," "attempt," or variations of these or similar
words, identify forward-looking statements. These forward-looking
statements by their nature are estimates of future results only and
involve substantial risks and uncertainties, including but not
limited to risks associated with the uncertainty of future
financial results, additional financing requirements, development
of new products, our ability to complete our product testing and
launch our product commercially, the acceptance of our product in
the marketplace, the uncertainty of the laws and regulations
relating to cannabis, the impact of competitive products or
pricing, technological changes, the effect of economic conditions
and other uncertainties detailed from time to time in our reports
filed with the Securities and Exchange Commission, available at
www.sec.gov or www.eviolabs.com
Company Contact:
EVIO Inc.
Bend, OR
www.EVIOlabs.com
888.544.EVIO
info@EVIOlabs.com
Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com